C Pradier to Natalizumab
This is a "connection" page, showing publications C Pradier has written about Natalizumab.
Connection Strength
0.307
-
Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS? Rev Neurol (Paris). 2017 Apr; 173(4):222-224.
Score: 0.307
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.